This week LABION team is participating at the Nanomed Europe conference co-organized by the ETPN and Empa, about nanomedicine and translation to market of nanomedical products.

Marzia Bedoni, head of the LABION, is the leader of the Clinical Interface & Social Impact working group of ETPN (European Technology Platform). The main challenge for this working group is to take the lead of the whole development process, being the protagonists both at the beginning – as unmet needs experts – and at the end, as representatives of the final market.
Would you like to play a leading role in the new personalised medicine, from a real world application perspective? Write to

During Nanomed Europe conference, Alice Gualerzi, Silvia Picciolini and Francesca Rodà will present the LABION activities about the use of Raman Spectroscopy and Surface Plasmon Resonance imaging for the investigation of neurological and cerebrovascular diseases.

post etpn

No Comments Yet.

Leave a comment